SENJU PHARMACEUTICAL AND NOVALIQ ENTER INTO LICENSE AGREEMENT FOR NOV03 (PERFLUOROHEXYLOCTANE OPHTHALMIC SOLUTION) FOR THE TREATMENT OF DRY EYE DISEASE IN JAPAN
Senju Pharmaceutical Co., Ltd., a researched-based Japanese pharmaceutical company focusing the field of ophthalmology, and Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on its unique EyeSol
